ResMed Inc. (RMD) is a publicly traded Healthcare sector company. As of July 8, 2026, RMD trades at $209.13 with a market cap of $31.68B and a P/E ratio of 20.95. RMD moved -4.81% today. Year to date, RMD is -9.60%; over the trailing twelve months it is -14.30%. Its 52-week range spans $180.27 to $293.81. Analyst consensus is buy with an average price target of $256.09. Rallies surfaces RMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ResMed Inc. (RMD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RMD moved -4.81% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $209.13 |
| Market Cap | $31.68B |
| P/E Ratio | 20.95 |
| EPS | $10.41 |
| Dividend Yield | 0.60% |
| 52-Week High | $293.81 |
| 52-Week Low | $180.27 |
| Volume | 696.44K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.54B |
| Net Income | $1.52B |
| Gross Margin | 61.59% |
14 analysts cover RMD: 0 strong buy, 8 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $256.09.